ΒιΆΉ΄«Γ½

Meeting Coverage

ECTRIMS

European Committee for Treatment and Research in Multiple Sclerosis

McDonald Criteria Revisions Signal Shift Toward MS as a Biologically Based Disease

Some cases of radiologically isolated syndrome will be considered multiple sclerosis

ECTRIMS over a photo of Bella Center Copenhagen in Copenhagen, Denmark.

Latest ECTRIMS Meeting Coverage

Women With MS Less Likely to Receive Treatment Than Men

Is "therapeutic inertia" to blame?

September 21, 2024
Kids With MS May Have Better Outcomes When Started on High-Efficacy Treatment Early

Starting monoclonal antibody therapy during childhood reduced long-term disability

September 20, 2024
Tolebrutinib Slows Disability in Non-Relapsing Secondary Progressive MS

Liver toxicity may still be a concern

September 20, 2024
Blood Markers Help Predict MS Disease Progression

Patients with high NfL at disease onset may benefit from high-efficacy treatments

September 19, 2024
Higher Comorbidity Burden in Multiple Sclerosis Tied to Worse Outcomes

Analysis looks at pooled data of 17,000 MS trial participants

September 18, 2024
S1P Receptor Modulator May Boost Cognitive Processing Speed in Early MS

Ozanimod led to test score improvements in interim analysis

October 19, 2023
BTK Inhibitor Reduces Brain Lesions in Relapsing MS

Subgroup analysis shows brain penetration

October 19, 2023
Neurofilament Light Predicts MS Worsening in Silent Progression

NfL changes occurred in advance of, not coincident with, clinical worsening

October 17, 2023
Path to Multiple Sclerosis Cure on the Horizon

MS field faces immense opportunity to move beyond disease suppression, keynote speaker says

October 15, 2023
Subcutaneous Ocrelizumab Not Inferior to IV Infusion

Both provided rapid B-cell depletion

October 14, 2023
Novel Drug Shows Promise in Multiple Sclerosis

CD40 ligand inhibitor leads to sustained reduction of MRI disease activity

October 13, 2023
Pragmatic Trials May Help Increase Minority Participation in MS Research

DELIVER-MS shows racial and ethnic diversity in clinical trials can be improved

November 2, 2022
Higher Relapse Rate With Rituximab vs Ocrelizumab in MS Registry Data

Rituximab did not show non-inferiority in comparative effectiveness study

November 1, 2022
Can First MS Symptoms Be Delayed?

ARISE trial investigates radiologically isolated syndrome

October 31, 2022

Videos

ECTRIMS Future Focus
November 2023
ECTRIMS Video Pearls
November 2023